Abstract
Modafinil is a wakefulness promoting agent used in the treatment of narcolepsy. It is also beneficial in patients with multiple sclerosis and with Parkinson's disease who complain of fatigue and sleepiness. We and others have shown that patients with MS-related fatigue have a deficit of arousal that can be corrected by modafinil. The mechanisms of action of modafinil are not clearly elucidated, but it is known to target the dopamine transporter, and to enhance the availability of dopamine and catecholamine neurotransmitters.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.